Abstract
The substrate selectivities of an anti-phosphonate and an anti-phosphate kinetically homogeneous polyclonal catalytic antibody preparation and two hydrolytic enzymes were compared by using hapten-analogous and truncated carbonate and ester substrates each containing a 4-nitrophenolate leaving group. Syntheses of the truncated substrates devoid of recognition features in the non-leaving group parts of the substrates are reported. The relatively high kinetic selectivity of the more active anti-phosphonate antibody preparation is considered to depend on a relatively rigid catalytic site with substantial reaction centre specificity together with other important recognition interactions with the extended non-leaving group part of the substrate. In contrast, the less catalytically active, more flexible anti-phosphate antibody exhibits much lower kinetic selectivity for the substrate reaction centre comparable with that of the hydrolytic enzymes with activity much less dependent on recognition interactions with the non-leaving group part of the substrate. The ways in which haptenic flexibility and IgG architecture might contribute to the differential kinetic selectivities are indicated.
Keywords: catalytic site rigidity, hydrolytic catalytic antibody, kinetic characterization, lock and key, substrate selectivity, truncated carbonate and carboxylic ester substrate synthesis
Abbreviations: b.p., boiling point; m.p., melting point; PCA, polyclonal catalytic antibody preparation; PCA 271-22 (etc.), PCA isolated from the antiserum of sheep no. 271 in week 22 of the immunization programme (etc.); PLE, pig liver esterase
INTRODUCTION
There is growing awareness of the importance of structural dynamics in catalysis by some enzymes, including the interconversion of protein conformers and the dynamic aspect of substrate recognition. Recent clearly demonstrated examples of these phenomena have involved stopped-flow kinetic studies on natural variants of the papain family of cysteine proteinases using substrate-derived disulphide reactivity probes and a specific thionoester substrate [1–4]. Discussion of the relative catalytic effectiveness of enzymes and catalytic antibodies (e.g. [5]) has included consideration of architectural differences between these two types of protein catalyst and their consequences for structural dynamics [6–11].
In the present paper, we compare the kinetic selectivities of two kinetically homogenous, enzyme-free, polyclonal catalytic antibody preparations. Each was generated by one of two closely related immunogens differing only in the flexibility of the atomic framework around the structural motifs of the haptens analogous to the reaction centres of the corresponding (cognate) substrates. As discussed in [12], the systematic study of the relationships between haptenic structure, antibody recognition and catalytic activity is facilitated by the use of polyclonal preparations. Of particular note is that: (i) generation of polyclonal catalytic antibodies samples the entirety of the immune response, (ii) polyclonal IgG preparations investigated to date in different laboratories have not deviated from single-phase (Michaelis–Menten) saturation kinetics, and (iii) polyclonal preparations, at least in our laboratories, are free from contamination by enzymes. The present study uses as its basis our recent demonstration [12] of the kinetic advantage of the antibody preparation produced by using the more rigid, phosphonate, immunogen (1, Figure 1) towards its cognate ester substrate (2, Figure 1) over that produced by using the less rigid, phosphate, immunogen (3, Figure 1) towards its cognate carbonate substrate (4, Figure 1). At pH 8.0, there is a 13-fold advantage in kcat/knon-cat and a 100-fold advantage in the proficiency constant, kcat/knon-cat·Km. These kinetic data show that increasing the rigidity from that of the phosphate/carbonate system (3/4) to that of the phosphonate/ester system (1/2) results in substantial enhancement of the catalytic activity towards the substrate with a structure analogous to that of the relevant hapten. A haptenic structure that has fewer degrees of freedom around the reaction centre determinant would be expected to elicit antibodies with fewer relevant conformational variants associated with the reaction centre binding site. It seemed possible that the anti-phosphonate antibody might possess more ‘lock and key’ character in substrate binding than the anti-phosphate antibody and thus exhibit greater selectivity for a substrate with appropriate reaction centre structure. The present paper provides evidence for this hypothesis and reports also a greater dependence of catalytic activity on non-reaction centre recognition in the case of the anti-phosphonate antibody. The kinetic selectivity characteristics of the two types of catalytic antibody are compared also with those of two hydrolytic enzymes, the serine proteinase α-chymotrypsin (reviewed in [13]) and the serine carboxylesterase, PLE (pig liver esterase) (see [14] for a review of esterases).
Figure 1. Structures of immunogens and substrates.
1 is the 4-nitrophenyl phosphonate immunogen used to elicit PCA 2649-16; 2 is the full-length cognate carboxylic ester substrate for this anti-phosphonate antibody preparation; 3 is the 4-nitrophenyl phosphate immunogen used to elicit PCA 271-22; 4 is the full-length cognate carbonate ester substrate for this anti-phosphate antibody preparation; 5 is the truncated carboxylic ester substrate devoid of the non-leaving group recognition features of 2; 6 is the truncated carbonate substrate devoid of the non-leaving group recognition features of 4.
MATERIALS AND METHODS
Chemicals
Unless otherwise stated, chemicals were from Sigma-Aldrich, Poole, Dorset, U.K.
Antibodies
The PCA (polyclonal catalytic antibody) preparation (PCA 271-22, isolated from the antiserum of sheep no. 271 in week 22 of the immunization programme) elicited using the 4-nitrophenyl phosphate immunogen 3 (Figure 1) and PCA 2649-16 (designated in an analogous way) elicited by using the 4-nitrophenyl phosphonate immunogen 1 (Figure 1) were produced as described in [15] and [12] respectively. The upper limits of the active-site contents of the PCA preparations were shown to be approx. 10% of the total IgG content by using a combination of pre-steady-state and steady-state kinetics described previously [16,17] and reviewed in [18].
Enzymes
The bovine pancreatic enzyme α-chymotrypsin was obtained from Fluka, Gillingham, Dorset, U.K. as a 3×crystallized product stated to be free from low Mr peptide fragments. Immediately before use, the solid enzyme (40 mg) was dissolved in 0.1 M KCl (2 ml containing 1 mM EDTA) and subjected to gel filtration on a Sephadex G-25 column (25 cm×2 cm) to remove residual low Mr material. Elution was with 0.1 M KCl solution containing 1 mM EDTA, and the concentration of enzyme protein was determined spectrophotometrically at 282 nm (ε282=5.0×104 M−1·cm−1 [19]).
The source of PLE (EC 3.1.1.1) was freeze-dried powder supplied by Fluka, and the purification was similar to that described for the rat kidney carboxylesterase [20] with DEAE-cellulose replaced by DEAE-Sephadex and the introduction of FPLC technology. The concentration of enzyme protein was determined spectrophotometrically at 280 nm with ε280=2.32×105 M−1·cm−1 calculated from the published value of A1cm1%=13.8 and Mr=1.68×105 [21].
Active-site titration of both enzymes was performed by using N-trans-cinnamoylimidazole as titrant [22]. Typical contents of active enzyme were 95–100% in both cases.
Immunogens and full-length cognate substrates
The syntheses of these compounds have been reported previously: the phosphonate immunogen 1 and the carboxylic ester substrate 2 in [12], the phosphate immunogen 3 in [15], and the carbonate substrate 4 in [23].
New syntheses: the truncated substrates
Truncated carboxylic ester substrate 4-nitrophenyl propanoate 5 (Scheme 1a)
Triethylamine (873 mg, 8.62 mmol, 1.2 ml) was added to a stirred mixture of 4-nitrophenol (1 g, 7.19 mmol) in anhydrous acetonitrile (15 ml) at 0 °C, followed by aliquots of propanoyl chloride (266 mg, 2.87 mmol, 250 μl) at t=0, t=10 and t=20 min. The ice bath was removed, and the mixture was stirred for 90 min and then diluted in ethyl acetate (100 ml) at room temperature (22 °C). The mixture was washed with cold water (3×60 ml) and dried over anhydrous MgSO4, which was then removed by filtration. Evaporation of the solvent left the required product as a white solid. This was recrystallized twice from ethyl acetate/petroleum ether, b.p. (boiling point) 60–80 °C (50:50). The white crystals were dried in vacuo and had a m.p. (melting point) of 58–62 °C. TLC (ethyl acetate): Rf=0.75. 1H-NMR (360 MHz, deuterated chloroform): δ 8.3 (2H, d, J 9.2 Hz, HA of ABq), 7.3 (2H, d, J 9.2 Hz, HB of ABq), 2.6 (2H, q, J 7.5 Hz, -COCH2), 1.3 (3H, t, J 7.5 Hz, -COCH2CH3). MS: m/z=195 (M+).
Truncated carbonate substrate methyl 4-nitrophenyl carbonate 6 (Scheme 1b)
4-Nitrophenyl chloroformate (1 g, 5 mmol) was added over 20 min to a stirred mixture of anhydrous acetonitrile (10 ml), methanol (150 mg, 5 mmol, 201 μl) and triethylamine (502 mg, 5 mmol, 692 μl) at room temperature. The mixture was then left to stir for 1 h, during which time triethylamine hydrochloride precipitated. Ethyl acetate was added to the mixture which was then washed with cold water (3×15 ml). The organic layer was dried over anhydrous MgSO4, which was then removed by filtration. Evaporation of the filtrate left the required product as a white solid, which was recrystallized from ethyl acetate/petroleum ether, b.p. 60–80 °C (7:3) and had a m.p. of 112–116 °C. TLC (ethyl acetate/petroleum ether 1:5) Rf=0.41. 1H-NMR (360 MHz, deuterated chloroform): δ 8.3 (2H, d, J 8.7 Hz, HA of ABq), 7.4 (2H, d, J 8.7 Hz, HB of ABq), 4.0 (3H, s, -OCO2CH3). MS: m/z=196 (M-H+).
Kinetics
Kinetic studies of the hydrolysis of the 4-nitrophenyl carboxylic ester substrates 2 and 5 and of the 4-nitrophenyl carbonate substrates 4 and 6 catalysed by PCA 271-22, PCA 2649-16, α-chymotrypsin and PLE were performed in potassium phosphate buffer pH 8.0 (devoid of Cl−, see [12]) containing 10% (v/v) acetonitrile at 25 °C and I 0.3. It is important to note that there is no evidence for inhibition by phosphate [12]. The values of [IgG] and [active enzyme] (in μM) for the various catalyses were as follows: for PCA 271-22 and PCA 2649-16, with 4, 1.2, with 2, 8.0, and with 5 and 6, 10.0; for α-chymotrypsin, 0.48 in all cases; for PLE, with 4, 0.048, and with the other three substrates, 0.48. The enzyme-catalysed reactions were studied also over pH ranges approx. 4–10 or 5–9 in acetate, phosphate and carbonate buffers under otherwise similar conditions. The reactions were initiated by the addition of various volumes of solutions of substrate in pure anhydrous acetonitrile to produce ranges of concentration in 1 ml reaction mixtures containing a total acetonitrile content of 10% (v/v). The release of 4-nitrophenolate from the substrate was monitored at 410 nm using a Cary 1 spectrophotometer over 2–5 min. Initial rates (viobs) were calculated in M·s−1 from absorbance–time data by using the value of ε410 calculated from the relationship ε410=16963/(1+[H+]/Ka) M−1·cm−1, where Ka=10−7.15 M. The rates of antibody-catalysed reactions were corrected by subtracting the rates of reaction determined in the presence of identical concentrations of IgG from NSS (normal sheep serum). Those of the enzyme-catalysed reactions were corrected by subtracting the rates of the aqueous hydrolysis. In all cases, the rates of aqueous hydrolysis were used to calculate the first-order rate constants to provide the value of knon-cat (=kaq).
Parameter evaluation
The adherence of each set of the corrected initial rate, (vi) against [S]0 data to the Michaelis–Menten equation was first checked by observation of an intersecting pattern of lines in a direct linear plot [24] and the linearity of an [S]0/vi against [S]0 plot [25]. Values of the parameters Vmax and Km were then determined by using the weighted non-linear regression program in SIGMAPLOT 5.0 (Jandel Scientific) using a Research Machines Pentium III PC/500 MHz. An error structure of constant relative error was assumed and weighting factors were inversely proportional to vi2. Values of the catalytic rate constant (kcat) were calculated from kcat=10Vmax/2[IgG]=5Vmax/[IgG] (10% of the IgG catalytic and two potential active centres per molecule) to provide lower limits for this parameter [16–18].
Preliminary characterization of the pH-dependence of kcat and kcat/Km was carried out by using the multitasking application program SKETCHER [26] written in ANSI C running under RISCOS on an Acorn Archimedes microcomputer [12].
RESULTS AND DISCUSSION
Design and synthesis of the truncated substrates 5 and 6
The objective of the present study was to investigate the substrate selectivities of the anti-phosphonate (PCA 2649-16) and anti-phosphate (PCA 271-22) catalytic antibody preparations and compare them with those of relevant enzyme preparations as discussed in the Introduction. One aspect of this involved the hypothesis that the anti-phosphonate antibody might exhibit greater reaction centre selectivity than either the anti-phosphate antibody or the enzymes. The other was concerned with the dependence of catalytic activity on non-reaction centre recognition. The latter was addressed by comparing the kinetic characteristics of the two types of antibody preparation, and the proteinase and esterase enzymes towards the ‘full-length’ hapten-analogous carboxylic ester and carbonate substrates, 2 and 4 respectively, with those towards the truncated substrates 5 and 6. In 5 and 6, the potential recognition features in the non-leaving group parts of 2 and 4 (the phenyl ring and amide group) have been deleted. The 4-nitrophenyl group, which provides a chromogenic leaving group in all four substrates and a strongly antigenic group in the immunogens 1 and 3, is retained. The inclusion of identical leaving group determinants in the haptens and identical leaving groups in the corresponding substrates was essential to the investigation of the kinetic consequences of the variation in the flexibility of the atomic framework of the reaction centre and the analogous structural motif of the haptens [12]. Equally, the retention of the 4-nitrophenyl leaving group is essential to the investigations reported in the present paper. The synthesis of the truncated carboxylic ester 5 was achieved by condensation of propanoyl chloride with 4-nitrophenol and that of the truncated carbonate ester 6 by condensation of 4-nitrophenyl chloroformate with methanol [Scheme 1, (a) and (b) respectively].
Scheme 1. Synthesis of the truncated substrates 5 and 6.
(a) Reaction of propanoyl chloride with 4-nitrophenol in anhydrous acetonitrile and triethylamine produced the truncated carboxylic ester substrate, 4-nitrophenyl propanoate (5). (b) Reaction of 4-nitrophenyl chloroformate with methanol in anhydrous acetonitrile and triethylamine produced the truncated carbonate substrate, 4-nitrophenyl carbonate (6).
Substrate selectivities: the data
The kinetic characteristics of the two hydrolytic antibody preparations and the two hydrolytic enzymes at pH 8.0 are collected in Table 1. In all cases, single-phase (Michaelis–Menten) saturation kinetics were observed, as demonstrated for the antibody preparations towards 2 and 4 in [12]. Substrates are designated cognate if the reaction centre is analogous to the corresponding haptenic determinant, i.e. carbonate for the anti-phosphate antibody and carboxylic ester for the anti-phosphonate antibody, and non-cognate if the opposite is true. As in [12], values of kcat for the antibody-catalysed reactions were calculated by assuming that 10% of the IgG is catalytic (see the Materials and methods section) and possess two potential active centres per molecule, i.e. kcat=5Vmax/[IgG]. This calculation provides the lower limits for the kcat values. It is important to emphasize that the present paper makes use of ratios of the kinetic parameters for a particular antibody with pairs of substrates. These ratios, of course, are not affected by the fraction of the IgG assumed to be catalytic if this is the same for the evaluation of the antibody with each substrate. Values for the enzyme-catalysed reactions were calculated from kcat=Vmax/[E]T, where [E]T was determined by active-site titration [22]. Values of kcat/knon-cat provide correction for differences in intrinsic reactivity of the substrate towards aqueous (i.e. H2O and HO−) hydrolysis. The proficiency constant, kcat/knon-cat·Km, introduced by Radzicka and Wolfenden [27], is related to the well-known specificity constant, kcat/Km, with account taken of the intrinsic reactivity of the substrate.
Table 1. Kinetic parameters for hydrolysis at 25 °C in phosphate buffer, pH 8.0, I=0.3, containing 10% (v/v) acetonitrile catalysed by anti-phosphate PCA 271-22, anti-phosphonate PCA 2649-16, PLE and α-chymotrypsin (α-Ch).
Substrates are designed variously as cognate (C), non-cognate (N), full-length (FL) and truncated (T); values of kcat were calculated for the antibodies as 5Vmax/[IgG] and for the enzymes as Vmax/[E]T, where [E]T is the active site concentration determined by titration with N-trans-cinnamoylimidazole; observed initial rates were corrected for background hydrolysis as described in the Materials and methods section; values of kcat/knon-cat permit comparisons of kcat values for reactions of substrates of different intrinsic reactivities; similarly, values of kcat/knon-cat·KM, the proficiency constant, permit analogous comparisons of kcat/KM; NMA, no measurable activity over background; NA, not applicable.
| Catalyst | Substrate | Reaction centre: cognate (C) or non-cognate (N) | Full-length (FL) or truncated (T) | KM (μM) | kcat (−1) | kcat/knon-cat | Proficiency constant kcat/knon-cat·KM (M−1) |
|---|---|---|---|---|---|---|---|
| PCA 271-22 | Carbonate 4 | C | FL | 290±44 | 1.8×10−1±0.2×10−1 | 900 | 3.1×106 |
| PCA 271-22 | Carbonate 6 | C | T | 104±116 | 1.6×10−3±0.5×10−3 | 29 | 2.8×105 |
| PCA 271-22 | Ester 2 | N | FL | 36±3 | 7.8×10−3±0.003×10−3 | 250 | 6.9×106 |
| PCA 271-22 | Ester 5 | N | T | NMA | NMA | – | – |
| PCA 2649-16 | Ester 2 | C | FL | 39±2 | 3.8×10−1±0.08×10−1 | 1.2×104 | 3.1×108 |
| PCA 2649-16 | Ester 5 | C | T | 237±65 | 9.0×10−3±2.0×10−3 | 160 | 6.5×105 |
| PCA 2649-16 | Carbonate 4 | N | FL | 97±69 | 1.5×10−2±0.4×10−2 | 77 | 7.9×105 |
| PCA 2649-16 | Carbonate 6 | N | T | NMA | NMA | – | – |
| PLE | Carbonate 4 | NA | FL | 7.1±0.4 | 7.1±0.1 | 3.5×104 | 5.0×109 |
| PLE | Carbonate 6 | NA | T | 190±39 | 3.3±0.5 | 1.6×105 | 8.4×108 |
| PLE | Ester 2 | NA | FL | 25±2 | 3.8±0.04 | 1.2×105 | 4.7×109 |
| PLE | Ester 5 | NA | T | 72±8 | 23±2 | 4.0×105 | 5.6×109 |
| α-Ch | Carbonate 4 | NA | FL | 10±1 | 1.3±0.04 | 6.5×103 | 6.8×108 |
| α-Ch | Carbonate 6 | NA | T | 74±13 | 0.03±0.004 | 1.5×103 | 2.1×107 |
| α-Ch | Ester 2 | NA | FL | 21±0.02 | 0.03±0.01 | 9.0×102 | 4.2×107 |
| α-Ch | Ester 5 | NA | T | 33±4 | 0.02±0.001 | 3.8×102 | 1.2×107 |
Rigidity and reaction centre selectivity
Comparison of the kinetic characteristics of the examples of the two types of catalytic antibody preparation (anti-phosphonate and anti-phosphate) used (i.e. PCA 2649-16 and PCA 271-22 respectively), each with its own full-length cognate substrate (ester 2 and carbonate 4 respectively), demonstrated the kinetic advantage of the former, 13-fold in terms of kcat/knon-cat and 100-fold in terms of kcat/knon-cat·Km [12]. These data suggest that, in the examples studied, decreasing the flexibility of the phosphate/carbonate system (3/4) to that of the phosphonate/ester system (1/2) results in substantial enhancement of the catalytic effectiveness of the catalytic antibody preparation. This conclusion accords with the concept that antibodies with fewer relevant conformational variants associated with reaction centre binding would be expected to result from the use of a haptenic structure with fewer degrees of freedom around the reaction centre determinant. Improvement in catalytic effectiveness would be expected to be the consequence of the production of at least one variant with better complementarity to the reaction transition state. Presumably in the case of the antibody preparations used in the present work, one catalytically effective conformational variant predominates substantially in each preparation in view of the kinetic homogeneity observed for both preparations. The apparent generality of kinetic homogeneity in polyclonal preparations is discussed in [12].
The possible relationship between decreased conformational flexibility and catalytic effectiveness discussed above predicted greater substrate selectivity when the reaction centre is varied in the case of the less flexible anti-phosphonate antibody (PCA2649-16). Support for this predication is provided by comparison of ratios of the relevant parameters collected in Table 1. Thus the anti-phosphonate antibody discriminates in favour of its own full-length cognate substrate (ester 2), relative to that (carbonate 4) of the other antibody, more effectively than the anti-phosphate antibody in terms of both kcat/knon-cat [(1.2×104/77=156)/(900/250=3.6)=43] and kcat/knon-cat·Km [(3.1×108/7.9×105=392)/(3.1×106/6.9×106=0.45)=871] ratios.
The difference in the reaction centre selectivity between these examples of the two types of antibody is demonstrated also by the parameter ratios for the catalysis by each antibody with the same full-length substrate (ester 2 or carbonate 4). The relevant ratios show that when each antibody is presented with the cognate substrate for the anti-phosphonate antibody (ester 2), the anti-phosphonate antibody is more effective than the anti-phosphate antibody (by 48-fold in terms of kcat/knon-cat and by 45-fold in terms of kcat/knon-cat·Km). In contrast, when each antibody is presented with the cognate substrate for the anti-phosphate antibody (carbonate 4), the anti-phosphate antibody is the more effective, but to a much smaller degree (by only 11-fold in terms of kcat/knon-cat and by only 4-fold in terms of kcat/knon-cat·Km). Once again, this demonstrates greater substrate selectivity in the case of the less flexible, anti-phosphonate antibody (PCA 2649-16). This suggests that, whereas the relative rigidity of the catalytic site of the anti-phosphonate antibody is advantageous in binding an appropriate conformation of the cognate ester substrate, an analogous conformation is achieved with difficulty for the carbonate substrate.
Contributions of the non-reaction centre recognition features of the substrates to the catalytic effectiveness of the antibodies
There is considerable evidence in enzyme catalysis that some binding interactions not only locate substrates in appropriate enzyme loci, but also transmit signals with a chemical consequence to catalytic sites (e.g. [28] and references therein). In the present work, we investigated the extent to which the potential non-reaction centre recognition features of the full-length substrates 2 and 4, with retention of the common 4-nitrophenolate leaving group, contribute to the catalytic effectiveness of both the anti-phosphonate and anti-phosphate antibodies. It is particularly noteworthy that the value of the proficiency constant for catalysis by the anti-phosphonate antibody of hydrolysis of its full-length cognate (ester) substrate 2 is 477-fold greater than that for its catalysis of the truncated ester substrate 5. In contrast, the analogous ratio for the anti-phosphate antibody and its full-length cognate (4) and truncated (6) carbonate substrates is only 11 (43 times less). Thus not only does the antibody with the more rigid catalytic site exhibit greater reaction centre selectivity with full-length substrates, but also it appears to make more effective kinetic use of binding the recognition features in the non-leaving group part of the substrate. It appears, therefore, that the more rigidly defined active centre region postulated for the anti-phosphonate antibody requires specific interactions involving much of the substrate structure to produce the enhanced catalytic activity relative to that of the anti-phosphate antibody. This conclusion is supported by the finding that the anti-phosphonate antibody did not provide observable catalysis of the hydrolysis of the truncated substrate with the non-cognate (carbonate) reaction centre 6 even when the [IgG] was increased to 10 μM.
Comparison of the substrate-selectivity characteristics of PCA 271-22 and PCA 2649-16 with those of PLE and α-chymotrypsin
To show how the substrate-selectivity characteristics of the two antibody preparations differed not only from each other, but also from those of two hydrolytic enzymes (an esterase and a proteinase), we evaluated the catalytic characteristics of PLE and α-chymotrypsin using the same full-length (2 and 4) and truncated (5 and 6) substrates designed for use with the antibodies. The data are collected in Table 1.
α-Chymotrypsin is known to exert specificity for substrates with a hydrophobic substituent in the side chain of the amino acid residue contributing the carbonyl group of the scissile bond (the P1-position) as an occupant for the S1-subsite. Substrates 2 and 4 were therefore predicted to serve as reasonably effective substrates for α-chymotrypsin. This is confirmed by the values of the proficiency constant (Table 1). The fact that preliminary data for the forms of the pH-dependence of kcat and kcat/Km for the catalysed hydrolysis of both 2 and 4 are those for specific substrates (sigmodial with pKa approx. 7 for kcat and bell-shaped for kcat/Km with pKas of approx. 7 and 8.5 [13]) suggests that the well-known mechanism of catalysis by α-chymotrypsin is applicable also to these substrates.
PLE catalyses the hydrolysis of low Mr aliphatic and aromatic esters with broad specificity [14], and the values of the proficiency constant (Table 1) confirm that 2 and 4 serve as effective substrates. The pH-dependent kinetic characteristics of PLE are not well established, but our preliminary kinetic data indicate that both kcat and kcat/Km for both 2 and 4 are close to optimal at pH 8, the pH at which the present studies were performed.
It is particularly noteworthy that neither enzyme exhibits the high selectivity shown by the anti-phosphonate antibody (PCA 2649-16). This is the case both for one full-length substrate relative to the other and for a full-length substrate relative to the related truncated substrate. PLE exhibits little preference for either full-length substrate [(PLE and 2)/(PLE and 4): 3.6 for kcat/knon-cat values and 0.9 for kcat/knon-cat·Km values] and the preference of α-chymotrypsin for the full-length carbonate [(α-chymotrypsin and 4)/(α-chymotrypsin and 2): 7 for kcat/knon-cat values and 16 for kcat/knon-cat·Km values] is small relative to the preference shown by PCA 2649-16 for ester substrate 2 [(PCA 2649-16 and 2)/(PCA 2649-16 and 4): 156 for kcat/knon-cat values and 392 for kcat/knon-cat·Km values]. The greater selectivity of α-chymotrypsin than that of PLE for the full-length carbonate substrate (as opposed to the full-length ester substrate) might reflect the better fit of the phenyl ring of the non-leaving group in or near the S1-subsite. This is supported by the larger effect of truncation in the case of α-chymotrypsin than in the case of PLE.
Concluding comment
The relatively high kinetic selectivity of the anti-phosphonate antibody preparation (PCA 2649-16) is suggested to depend on a relatively rigid catalytic site with substantial reaction centre specificity together with other important recognition interactions with the extended non-leaving group part of the substrate. In contrast, the less catalytically active anti-phosphate antibody (PCA 271-22) exhibits much lower kinetic selectivity for the substrate reaction centre, comparable with that of the hydrolytic enzymes, with activity much less dependent on recognition interactions with the non-leaving group part of the substrate. One way in which haptenic flexibility could affect catalysis, discussed in [29], is that a flexible hapten might elicit an antibody-binding pocket that binds substrates partly in ground-state conformations. These might not proceed readily to transition state and/or products due to conformational constraints. Flexible haptens might ‘collapse’ into low-energy structures that are recognized by the antibodies, but may not proceed along the entire reaction co-ordinate. Such considerations could have implications also for substrate selectivity. The ‘lock and key’ character deduced for substrate binding by PCA 2649-16, which is not usually associated with enzyme catalysis, presumably derives from the IgG architecture. In anti-4-nitrophenyl phosphate/phosphonate catalytic antibodies, active sites are located in β-sandwich pockets, whereas in many hydrolytic enzymes they are in extended clefts which would be expected to provide more opportunities for conformational mobility (e.g. [30]). The hypothesis suggested by the results of the present study needs to be investigated with other antibody–substrate combinations with a view to revealing any general concepts that may exist.
Acknowledgments
We thank the Engineering and Physical Sciences Research Council for an earmarked research studentship for S.S., the Biotechnology and Biological Sciences Research Council for a postdoctoral research assistantship for S.G. and a research studentship for S.H., and the EC (ERBF-MRXCT 980193) for research studentships for G.B. and J.F.A.
References
- 1.Brocklehurst K., Watts A. B., Patel M., Verma C. S., Thomas E. W. Cysteine proteinases. In: Sinnott M. L., editor. Comprehensive Biological Catalysis. vol. 1. London: Academic Press; 1998. pp. 351–423. [Google Scholar]
- 2.Reid J. D., Hussain S., Sreedharan S. K., Bailey T. S., Pinitglang S., Thomas E. W., Verma C. S., Brocklehurst K. Variation in aspects of cysteine proteinase mechanism deduced by spectroscopic observation of dithioester intermediates, kinetic analysis and molecular dynamic simulations. Biochem. J. 2001;357:343–352. doi: 10.1042/0264-6021:3570343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hussain S., Khan A., Brocklehurst K. A review of the developments in the study of cysteine proteinase mechanism: opportunities for the investigation of electrostatic effects and dynamic aspects of molecular recognition in enzyme chemistry. Recent Res. Devel. Biochem. 2002;3:653–677. [Google Scholar]
- 4.Hussain S., Pinitglang S., Bailey T. S., Reid J. D., Noble M. A., Resmini M., Thomas E. W., Greaves R. B., Verma C. S., Brocklehurst K. Variation in the pH-dependent pre-steady state and steady state kinetic characteristics of cysteine proteinase catalytic mechanism: evidence for electrostatic modulation of catalytic site function by the neighbouring carboxylate anion. Biochem. J. 2003;372:735–746. doi: 10.1042/BJ20030177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lindner A. B., Eshhar Z., Tawfik D. S. Conformational changes affect binding and catalysis by ester-hydrolysing antibodies. J. Mol. Biol. 1999;285:421–430. doi: 10.1006/jmbi.1998.2309. [DOI] [PubMed] [Google Scholar]
- 6.Padlan E. A. Anatomy of the antibody molecule. Mol. Immunol. 1994;31:169–217. doi: 10.1016/0161-5890(94)90001-9. [DOI] [PubMed] [Google Scholar]
- 7.Wilson I. A., Stanfield R. L. Antibody–antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 1994;4:857–867. doi: 10.1016/0959-440x(94)90267-4. [DOI] [PubMed] [Google Scholar]
- 8.Stewart J. D., Benkovic S. J. Transition-state stabilization as a measure of the efficiency of antibody catalysis. Nature (London) 1995;375:388–391. doi: 10.1038/375388a0. [DOI] [PubMed] [Google Scholar]
- 9.Charbonnier J. B., Golinelli P. B., Gigant B., Tawfik D. S., Chap R., Schindler D. G., Kim S. H., Green B. S., Eshhar Z., Knossow M. Structural convergence in the active sites of a family of catalytic antibodies. Science. 1997;275:1140–1142. doi: 10.1126/science.275.5303.1140. [DOI] [PubMed] [Google Scholar]
- 10.Gigant B., Charbonnier J. B., Eshhar Z., Green B. S., Knossow M. X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release. Proc. Natl. Acad. Sci. U.S.A. 1997;93:7857–7861. doi: 10.1073/pnas.94.15.7857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wedemayer G. J., Patten P. A., Wang L. H., Shultz P. G., Stevens R. C. Structural insights into the evolution of an antibody combining site. Science. 1997;276:1665–1669. doi: 10.1126/science.276.5319.1665. [DOI] [PubMed] [Google Scholar]
- 12.Gul S., Sonkaria S., Pinitglang S., Florez-Alvarez J., Hussain S., Thomas E. W., Ostler E. L., Gallacher G., Resmini M., Brocklehurst K. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving group determinant: evidence for the flexibility hypothesis. Biochem. J. 2003;376:813–821. doi: 10.1042/BJ20030716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wharton C. W. The serine proteinases. In: Sinnott M. L., editor. Comprehensive Biological Catalysis. vol. 1. London: Academic Press; 1998. pp. 345–379. [Google Scholar]
- 14.Quinn D. M., Feaster S. R. Esterases and lipases. In: Sinnott M. L., editor. Comprehensive Biological Catalysis. vol. 1. London: Academic Press; 1998. pp. 456–482. [Google Scholar]
- 15.Gallacher G., Jackson C. S., Searcey M., Badman G. T., Goel R., Topham C. M., Mellor G. W., Brocklehurst K. A polyclonal antibody preparation with Michaelian catalytic properties. Biochem. J. 1991;279:871–881. doi: 10.1042/bj2790871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Resmini M., Gul S., Carter S., Sonkaria S., Topham C. M., Gallacher G., Brocklehurst K. A general kinetic approach to investigation of active-site availability in macromolecular catalysts. Biochem. J. 2000;346:117–125. [PMC free article] [PubMed] [Google Scholar]
- 17.Topham C. M., Gul S., Resmini M., Sonkaria S., Gallacher G., Brocklehurst K. The kinetic basis of a general method for the investigation of active-site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions. J. Theor. Biol. 2000;204:239–256. doi: 10.1006/jtbi.2000.2011. [DOI] [PubMed] [Google Scholar]
- 18.Brocklehurst K., Resmini M., Topham C. M. Kinetic and titration methods for the determination of active-site content of enzyme and catalytic antibody preparations. Methods. 2001;24:153–167. doi: 10.1006/meth.2001.1176. [DOI] [PubMed] [Google Scholar]
- 19.Wilcox P. E. Chymotrypsinogens – chymotrypsins. Methods Enzymol. 1970;19:64–112. [Google Scholar]
- 20.Tsujita T., Miyada T., Okuda H. Purification of rat kidney carboxylesterase and its comparison with other tissue esterases. J. Biochem. 1998;103:327–331. doi: 10.1093/oxfordjournals.jbchem.a122269. [DOI] [PubMed] [Google Scholar]
- 21.Barker D. L., Jencks W. P. Pig liver esterase: physical properties. Biochemistry. 1969;8:3879–3889. doi: 10.1021/bi00838a001. [DOI] [PubMed] [Google Scholar]
- 22.Schonbaum G. R., Zerner B., Bender M. L. The spectrophotometric determination of the operational normality of an α-chymotrypsin solution. J. Biol. Chem. 1961;236:2930–2935. [PubMed] [Google Scholar]
- 23.Resmini M., Vigna R., Simms C., Barber J., Hagi-Pavli E., Watts A., Verma C., Gallacher G., Brocklehurst K. Characterisation of the hydrolytic activity of a polyclonal catalytic antibody preparation by pH-dependence and chemical modification studies: evidence for the involvement of Tyr and Arg sidechains as hydrogen bond donors. Biochem. J. 1997;326:279–287. doi: 10.1042/bj3260279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Eisenthal R., Cornish-Bowden A. The direct linear plot: a new graphical procedure for estimating enzyme kinetic parameters. Biochem. J. 1974;139:715–720. doi: 10.1042/bj1390715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wharton C. W., Cornish-Bowden A., Brocklehurst K., Crook E. M. Kinetics of the hydrolysis of N-benzoyl-L-serine methyl ester catalysed by bromelain and by papain: analysis of modifier mechanisms by lattice nomography, computational methods of parameter evaluation for substrate-activated catalyses and consequences of postulated non-productive binding in bromelain-and papain-catalysed hydrolyses. Biochem. J. 1974;141:365–381. doi: 10.1042/bj1410365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Brocklehurst S. M., Topham C. M., Brocklehurst K. A general kinetic equation for multiprotonic state reactions and rapid procedures for parameter evaluation. Biochem. Soc. Trans. 1990;18:598–599. doi: 10.1042/bst0180598. [DOI] [PubMed] [Google Scholar]
- 27.Radzicka A., Wolfenden R. A proficient enzyme. Science. 1995;267:90–93. doi: 10.1126/science.7809611. [DOI] [PubMed] [Google Scholar]
- 28.Kowlessur D., Topham C. M., Thomas E. W., O'Driscoll M., Templeton W., Brocklehurst K. Identification of signalling and non-signalling binding contributions to enzyme reactivity: alternative combinations of binding interactions provide for change in transition-state geometry in reactions of papain. Biochem. J. 1989;258:755–764. doi: 10.1042/bj2580755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Odenbaugh A. L., Helms E. D., Iverson B. L. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens. Bioorg. Med. Chem. 2000;8:413–426. doi: 10.1016/s0968-0896(99)00302-8. [DOI] [PubMed] [Google Scholar]
- 30.Golinelli-Pimpaneau B. Structural diversity of antibody catalysts. J. Immunol. Methods. 2002;269:157–171. doi: 10.1016/s0022-1759(02)00240-5. [DOI] [PubMed] [Google Scholar]


